about
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1AUnderstanding protein kinase CK2 mis-regulation upon F508del CFTR expressionA noncanonical sequence phosphorylated by casein kinase 1 in beta-catenin may play a role in casein kinase 1 targeting of important signaling proteinsPolyhalogenobenzimidazoles: synthesis and their inhibitory activity against casein kinasesInteraction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria.Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia.Phosphorylation of calmodulin fragments by protein kinase CK2. Mechanistic aspects and structural consequences.Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.The selectivity of inhibitors of protein kinase CK2: an update.Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localization.Semi-synthetic derivatives of natural isoflavones from Maclura pomifera as a novel class of PDE-5A inhibitors.Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylationCFTR mutations altering CFTR fragmentation.Thiol redox systems and protein kinases in hepatic stellate cell regulatory processes.Tyrosine phosphorylation and liver regeneration: A glance at intracellular transducers.Development and exploitation of CK2 inhibitors.Aurora-A site specificity: a study with synthetic peptide substrates.Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A.Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesisMBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinasesThe pleiotropic protein kinase CK2 phosphorylates HTLV-1 Tax protein in vitro, targeting its PDZ-binding motif.Lyn-mediated mitochondrial tyrosine phosphorylation is required to preserve mitochondrial integrity in early liver regeneration.Protein kinase CK2: a newcomer in the 'druggable kinome'.The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures.Autophosphorylation at the regulatory beta subunit reflects the supramolecular organization of protein kinase CK2.Label-free fluorescence detection of kinase activity using a gold nanoparticle based indicator displacement assay.Linear motifs in the C-terminus of D. melanogaster cryptochrome.Fatty Acid-Derived Pro-Toxicants of the Rat Selective Toxicant Norbormide.Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells.Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 InhibitorsIdentification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening ApplicationPyrazoloquinazoline Tricyclic System as Novel Scaffold to Design New Kinase CK2 InhibitorsUnique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 (‘casein kinase-2’)The Regulatory β Subunit of Protein Kinase CK2 Contributes to the Recognition of the Substrate Consensus Sequence. A Study with an eIF2β-Derived Peptide†
P50
Q27641451-61599736-4BF9-4FC3-9958-41D1E4F3FED2Q27655439-7A7C91EB-E849-407B-8623-0F49FB454584Q27670633-06A4EA4C-9232-4E70-8BB9-81CF601B9894Q27694649-35E62449-2A60-4BE1-9069-1F681086B8C2Q28202389-3F670DA4-990A-4F5E-ABDF-15DAFF529030Q28581363-6BEC28E6-E3FA-4F73-97F4-B71E3E044A40Q30010278-25009599-6E03-467D-9376-47303178A8C0Q30157536-783B7C52-813D-4D65-8168-D60AC2321B4BQ31117992-797921BE-E6D4-43CF-B00F-D4230850492BQ31117999-A7458F59-B391-495C-A838-F3CCCC212C18Q33347545-12BA3243-E338-4F0E-8290-1DA9B9B8891AQ34218099-9EEEE16F-29E4-4D7A-B73C-BCD1F3E4E891Q34483283-FA077834-D173-47C7-949C-438BCC24572BQ34521171-8D01EBE8-AEB1-481A-9092-6FA6FE524C80Q34994567-6D98C6E9-A5F6-4D5D-810E-5E96625425A9Q36525714-12A0BD21-F90C-4A4D-B2F0-756C98FF1087Q37694585-4DD120BC-2FBB-4E56-A627-1975F7F35D2DQ37970047-EE955F86-076E-46B2-B72F-C1EA98C9BFA5Q40342605-4DDE7FEB-BBA9-481E-A06F-9FDFD5BD98C0Q40388031-E9AAEB9C-F8C7-4AD7-9D76-7ED25AAB3002Q40989749-5AB49F75-89ED-4761-ABBA-7BF3C5C95DB7Q41788874-FDC72C0C-7641-4731-A479-940E4F8D8963Q41900237-71CB0635-6291-4536-9AE9-C6B695D48DEBQ43043529-9C42B881-5842-40AE-8998-6D39E8B51CF2Q43260808-925284A6-9441-4120-9E39-EC24A03026B0Q44016530-2425787E-4A93-47B6-8A08-5D4962D1AB99Q44564156-AAB743E6-6B83-4583-9703-E347216C73C4Q45052212-E21DFF80-477D-4ED1-8015-B028BFF1320DQ45164317-60F30A0B-EA90-4486-8BCA-F66B494487E7Q46834222-F1F21AA8-B8C3-419D-A417-E1EB39EC6D09Q46840846-6970C3BF-E7EE-47D2-BD4C-BE4047402C3DQ46965482-C64AA229-C544-46CA-802F-1E0D9BC6E843Q52676948-D711838C-7129-423D-B5E5-24F7171C6CD8Q52871449-DCC0E3D1-7958-44EA-A20D-BA1B47023E00Q54579340-915747AD-74EA-4AF1-B087-BB1165A6BFEDQ56979711-54DBEDAA-3DD9-4BBD-8F20-5BFDE5EB7348Q56979739-1AE3E657-1CE5-422A-922F-DBF8FA3A7626Q56979750-9FFA5445-2B52-4F75-BFB9-26099C7AEDF4Q58025134-D65030F2-DBD3-4A4D-9078-390B636AAE6CQ58037521-E36836FC-F940-47CB-9D51-6E916194871A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mario A Pagano
@ast
Mario A Pagano
@en
Mario A Pagano
@es
Mario A Pagano
@sl
type
label
Mario A Pagano
@ast
Mario A Pagano
@en
Mario A Pagano
@es
Mario A Pagano
@sl
prefLabel
Mario A Pagano
@ast
Mario A Pagano
@en
Mario A Pagano
@es
Mario A Pagano
@sl
P106
P21
P31
P496
0000-0003-4186-7658